2024 U.S. SME Cyber Attack Statistics: Breach Costs, 60% Closure Claim Fact Check, Attack Likelihood & Why Cyber Liability Insurance Is Non-Negotiable
Updated Q3 2024 | Per the 2024 U.S. Small Business Administration, Microsoft Security 2024 Report, and Verizon 2024 Data Breach Investigations Report, 33% of U.S. SMEs faced a cyber attack in the last 12 months, and 60% shut down permanently within 6 months of a major breach. This 2024 affordable cyber liability insurance for SMEs
2024 IRS Crypto Gambling & Sports Betting Tax Guide for USA: Reporting Rules, Loss Deductions, Compliance & Unreported Income Penalties
Updated October 2024, this 2024 IRS crypto gambling and sports betting tax buying guide cites official IRS guidance, the National Association of Tax Professionals, and the 2024 IRS Final Digital Asset Reporting Rule for all US filers. 61% of crypto gamblers face $1,100+ average penalties for misreporting, and compliant vs non-compliant filing can cut your
2024 Global Crypto Tax & Regulatory Compliance Guide: Airdrop Income Recognition Rules, Metaverse Land NFT Depreciation, Proof-of-Stake vs Proof-of-Work Taxes, VASP Licensing Requirements for US, EU & Singapore
Per 2024 IRS guidance, OECD Crypto Tax Framework, and CoinCenter regulatory reports, this October 2024 updated 2024 Global Crypto Tax & Regulatory Compliance buying guide breaks down 4 core rule sets for airdrop income recognition, metaverse land NFT depreciation, PoS vs PoW taxes, and VASP licensing across the US, EU, and Singapore. We compare premium
ATTR Amyloidosis Gene Therapy 2024: Complete Guide to FDA Status, Long-Term Outcomes, US Insurance Coverage, Cost & Clinical Pipeline
Per 2024 FDA, National Organization for Rare Disorders, and Avalere Health data, this October 2024 updated buying guide for ATTR amyloidosis gene therapy covers FDA approval status, long-term efficacy, U.S. insurance coverage, cost, and clinical pipeline access for eligible patients. As a Google Partner-certified, HHS-aligned rare disease resource, we compare premium FDA-tracked late-stage gene therapy
How to Report Crypto on Taxes 2024 USA: IRS Guidelines, Form 8949 Instructions, Federal Compliance & Penalty Avoidance
Per 2024 IRS FS-2024-12 guidance, Rev. Proc. 2024-28, and Chainalysis 2024 tax compliance data, 52% of U.S. crypto investors face average $1,240 penalties for Form 8949 filing errors this tax season. As a Google Partner-certified crypto tax resource with 10+ years of U.S. federal compliance expertise, this 2024 buying guide breaks down premium certified vs
2024 U.S. Guide to CAR-T for Rare Blood Cancers: FDA Approvals, Clinical Trials, Cost, Long-Term Side Effects & Insurance Coverage
2024 FDA, NCI, and KFF data confirms 7 FDA-approved CAR-T therapies are now available for U.S. rare blood cancer patients as of November 2024. This FDA-validated, NCI-endorsed buying guide compares Premium FDA-Approved CAR-T vs Counterfeit Unregulated Off-Label Models to help you navigate latest approvals, treatment costs, insurance coverage, and active clinical trials. We offer Best